Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The Journal of Infectious Diseases|September 22, 2017
Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis CoprevalenceNeesha Rockwood, Frederick Sirgel, Elizabeth Streicher, et al.Scientific Reports|February 11, 2016
The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolatesMichele Tomasicchio, Grant Theron, Elize Pietersen, et al.American Journal of Respiratory and Critical Care Medicine|June 15, 2017
Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic ResistanceJohn Z Metcalfe, Elizabeth Streicher, Grant Theron, et al.American Journal of Respiratory and Critical Care Medicine|October 23, 2012
Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratoryMarinus Barnard, Rob Warren, Nico Gey Van Pittius, et al.Antimicrobial Agents and Chemotherapy|September 13, 2017
Mycobacterium tuberculosis Subculture Results in Loss of Potentially Clinically Relevant HeteroresistanceJohn Z Metcalfe, Elizabeth Streicher, Grant Theron, et al.Plos One|April 25, 2015
High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosisElize Pietersen, Jonny Peter, Elizabeth Streicher, et al.American Journal of Respiratory and Critical Care Medicine|April 16, 2011
Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence settingGrant Theron, Jonny Peter, Richard van Zyl-Smit, et al.Antimicrobial Agents and Chemotherapy|June 27, 2022
Variants in Bedaquiline-Candidate-Resistance Genes: Prevalence in Bedaquiline-Naive Patients, Effect on MIC, and Association with Mycobacterium tuberculosis LineageEmmanuel Rivière, Lennert Verboven, Anzaan Dippenaar, et al.Plos One|May 14, 2013
Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South AfricaKaren Shean, Elizabeth Streicher, Elize Pieterson, et al.Genomics|April 16, 2021
A multi-phenotype genome-wide association study of clades causing tuberculosis in a Ghanaian- and South African cohortStephanie J Müller, Haiko Schurz, Gerard Tromp, et al.Pageof 2